Is TLIK.DE stock a buy after the pre-market bounce?

TLIK.DE stock is a speculative buy only for short-term traders seeking an oversold bounce. Cashflow and liquidity weaknesses favour small, disciplined positions with stops. For longer-term investors, fundamentals suggest caution.

What price target should traders watch for TLIK.DE stock?

Watch **€0.75** as an initial take-profit and **€0.90** as a secondary level. Meyka AI's model projects **€0.78** in three months, implying about **27.87%** upside from **€0.61**.

How does liquidity affect trading TLIK.DE stock?

Low liquidity (volume **375**, avg **704**) can cause wide spreads and slippage. Use limit orders, small sizes, and confirm moves with volume before entering trades in TLIK.DE stock.

What is the Meyka AI grade for TLIK.DE stock?

Meyka AI rates TLIK.DE with a score out of 100: **64.28 (B)** with a suggestion of **HOLD**. The grade factors in benchmarks, sector performance, growth, metrics, and analyst inputs.

DE Stocks

€0.61 TLIK.DE Arzneiwerk AG VIDA (XETRA) pre-market: Oversold bounce, watch €0.78 target

ByHuzaifa Zahoor February 13, 2026February 13, 2026

TLIK.DE stock trades at €0.61 pre-market on XETRA after modest intraday buying on light volume, creating an oversold bounce opportunity for short-term traders. The company, Arzneiwerk AG VIDA, shows a one-year decline of 34.41%, a market cap of €3,802,386, and weak liquidity with volume 375 versus avgVolume 704. Given negative EPS -0.13 and a negative PE, we frame this as a speculative bounce trade, not a long-term buy. Traders should weigh the upside potential against low free cash flow and tight trading ranges.